Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02576496
Title Study of EDO-S101, A First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mundipharma-EDO GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | FRA | ESP | DEU | CHE

Facility Status City State Zip Country Details
Mayo Clinic Phoenix Arizona 85054 United States Details
Mayo Clinic Cancer Center Jacksonville Florida 32224 United States Details
Columbia University Medical Center New York New York 10019 United States Details
University Hospitals Cleveland Seidman Cancer Center Cleveland Ohio 44106 United States Details
CHU de Caen Caen CS 3001 France Details
CHU ESTAING Service de thérapie Cellulaire et hématologique Clinique Clermont Ferrand 63000 France Details
CHU Lille Service des Maladies du Sang Lille 59037 France Details
Hopital Haut Leveque Pessac 33604 France Details
Centre hospitalier Lyon Sud Pierre Bénite 69495 France Details
University Hospital of Ulm, Department of Internal Medicine III Ulm 89081 Germany Details
Institute of Hematology "L. A. Seràgnoli", University of Bologna Bologna 40138 Italy Details
National Cancer Institute, Fondazione 'G. Pascale' Naples I-80131 Italy Details
VU medisch centrum Amsterdam 1081 HV Netherlands Details
Erasmus MC Rotterdam 3015 GD Netherlands Details
Institut Català d'Oncologia de Barcelona Hospitalet de Llobregat Barcelona 08908 Spain Details
Hospital Universitario de Salamanca Salamanca 37007 Spain Details
Hospital Universitario Marqués de Valdecilla Santander 39008 Spain Details
Kantonsspital St.Gallen St.Gallen 9007 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field